Bibliography

Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,500 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 7 September 2020) and papers are listed below and in the PDF below.

If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.

Download:

 (PDF, 3MB, 209 pages) 

This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website

 

 

Export 72 results:
Author [ Title(Asc)] Type Year
Filters: Author is Azoulay, L.  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
U
K. Tascilar, Azoulay, L., Dell'Aniello, S., Bartels, D. B., and Suissa, S., The Use of Telmisartan and the Incidence of Cancer, Am J Hypertens, vol. 29, pp. 1358-1365, 2016.
L. Azoulay, Yin, H., Filion, K. B., Assayag, J., Majdan, A., Pollak, M. N., and Suissa, S., The use of pioglitazone and the risk of bladder cancer in people with type 2 diabetes: nested case-control study, Bmj, vol. 344, p. e3645, 2012.
B. B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., The use of metformin and the incidence of lung cancer in patients with type 2 diabetes, Diabetes Care, vol. 36, pp. 124-9, 2013.
B. Smiechowski, Azoulay, L., Yin, H., Pollak, M. N., and Suissa, S., The use of metformin and colorectal cancer incidence in patients with type II diabetes mellitus, Cancer Epidemiol Biomarkers Prev, vol. 22, pp. 1877-83, 2013.
R. Pradhan, Yin, H., Yu, O. H. Y., and Azoulay, L., The Use of Long-Acting Insulin Analogs and the Risk of Colorectal Cancer Among Patients with Type 2 Diabetes: A Population-Based Cohort Study, Drug Saf, 2019.
M. Tuccori, Wu, J. W., Yin, H., Majdan, A., and Azoulay, L., The Use of Glyburide Compared With Other Sulfonylureas and the Risk of Cancer in Patients With Type 2 Diabetes, Diabetes Care, vol. 38, pp. 2083-9, 2015.
V. Mandilaras, Bouganim, N., Yin, H., Asselah, J., and Azoulay, L., The use of drugs acting on the renin-angiotensin system and the incidence of pancreatic cancer, Br J Cancer, vol. 116, pp. 103-108, 2017.
A. Douros, Abrahami, D., Yin, H., Yu, O. H. Y., Renoux, C., Hudson, M., and Azoulay, L., Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes, Epidemiology, vol. 29, pp. 904-912, 2018.
L. Azoulay, Soldera, S., Yin, H., and Bouganim, N., Use of Calcium Channel Blockers and Risk of Breast Cancer: A Population-based Cohort Study, Epidemiology, vol. 27, pp. 594-601, 2016.
L. Azoulay, Yin, H., Renoux, C., and Suissa, S., The use of atypical antipsychotics and the risk of breast cancer, Breast Cancer Res Treat, vol. 129, pp. 541-8, 2011.
J. Assayag, Pollak, M. N., and Azoulay, L., The use of aspirin and the risk of mortality in patients with prostate cancer, J Urol, vol. 193, pp. 1220-5, 2015.
B. D. Fox, Azoulay, L., Dell'Aniello, S., Langleben, D., Lapi, F., Benisty, J., and Suissa, S., The use of antidepressants and the risk of idiopathic pulmonary arterial hypertension, Can J Cardiol, vol. 30, pp. 1633-9, 2014.
F. Lapi, Azoulay, L., Kezouh, A., Benisty, J., Matok, I., Mugelli, A., and Suissa, S., The use of antidepressants and the risk of chronic atrial fibrillation, J Clin Pharmacol, vol. 55, pp. 423-30, 2015.
I
L. Azoulay, Dell'Aniello, S., Simon, T. A., Renoux, C., and Suissa, S., Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes, Eur Heart J, vol. 35, pp. 1881-7, 2014.
O. H. Yu, Filion, K. B., Azoulay, L., Patenaude, V., Majdan, A., and Suissa, S., Incretin-based drugs and the risk of congestive heart failure, Diabetes Care, vol. 38, pp. 277-84, 2015.
D. Abrahami, Yin, H., Yu, O. H. Y., Pollak, M. N., and Azoulay, L., Incretin-based Drugs and the Incidence of Colorectal Cancer in Patients with Type 2 Diabetes, Epidemiology, vol. 29, pp. 246-253, 2018.
J. Rouette, Yin, H., Yu, O. H. Y., Bouganim, N., Platt, R. W., and Azoulay, L., Incretin-based drugs and risk of lung cancer among individuals with type 2 diabetes, Diabet Med, 2020.
D. Abrahami, Douros, A., Yin, H., Yu, O. H., Faillie, J. L., Montastruc, F., Platt, R. W., Bouganim, N., and Azoulay, L., Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study, Bmj, vol. 363, p. k4880, 2018.
J. L. Faillie, Azoulay, L., Patenaude, V., Hillaire-Buys, D., and Suissa, S., Incretin based drugs and risk of acute pancreatitis in patients with type 2 diabetes: cohort study, Bmj, vol. 348, p. g2780, 2014.
I. Matok, Azoulay, L., Yin, H., and Suissa, S., Immortal time bias in observational studies of drug effects in pregnancy, Birth Defects Res A Clin Mol Teratol, vol. 100, pp. 658-62, 2014.
[Page last reviewed 7 September 2020]